Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial.

He M, Li Q, Zou R, Shen J, Fang W, Tan G, Zhou Y, Wu X, Xu L, Wei W, Le Y, Zhou Z, Zhao M, Guo Y, Guo R, Chen M, Shi M.

JAMA Oncol. 2019 May 9. doi: 10.1001/jamaoncol.2019.0250. [Epub ahead of print]


Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation.

Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhang Y, Chen M.

Cancers (Basel). 2018 Oct 10;10(10). pii: E378. doi: 10.3390/cancers10100378.


A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma.

Chen J, Fang A, Chen M, Tuoheti Y, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhu H, Zhang Y.

Cancer Med. 2018 Oct;7(10):5027-5035. doi: 10.1002/cam4.1787. Epub 2018 Sep 27.


High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis.

Shakya M, Zhou A, Dai D, Zhong Q, Zhou Z, Zhang Y, Li X, Bholee AK, Chen M.

Cancer Biomark. 2018;22(4):611-619. doi: 10.3233/CBM-170091.


Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis.

Chen J, Lu S, Zhang Y, Xu L, Chen J, Wang J, Chen M, Zhang R, Zhou Z.

J Cancer. 2018 Apr 19;9(10):1745-1753. doi: 10.7150/jca.24568. eCollection 2018.


The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.

Zhang Y, Huang J, Chen J, Yang K, Chen J, Xu L, Zhou Z, Chen M.

Cancer Manag Res. 2018 Mar 27;10:599-611. doi: 10.2147/CMAR.S160047. eCollection 2018.


Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma.

Zhang Y, Xi S, Chen J, Zhou D, Gao H, Zhou Z, Xu L, Chen M.

J Cancer. 2017 Aug 25;8(15):2992-3000. doi: 10.7150/jca.21038. eCollection 2017.


Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients.

Chen J, Huang J, Chen M, Yang K, Chen J, Wang J, Xu L, Zhou Z, Zhang Y.

J Cancer. 2017 Aug 25;8(15):2984-2991. doi: 10.7150/jca.20978. eCollection 2017.


Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study.

Huang Z, Zheng W, Zhang YJ, Xu L, Chen JB, Chen JC, Chen MS, Zhou Z.

Ultrasound Med Biol. 2017 Nov;43(11):2522-2529. doi: 10.1016/j.ultrasmedbio.2017.07.003. Epub 2017 Aug 12.


Expression of Pim-3 in colorectal cancer and its relationship with prognosis.

Zhou Z, Zhang R, Wang R, Zhang Y, Xu L, Chen J, Zhang J, Huang Z, Chen M, Pan Z.

Tumour Biol. 2016 Jul;37(7):9151-6. doi: 10.1007/s13277-016-4806-7. Epub 2016 Jan 14.


A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.

Zhou D, Zhang Y, Xu L, Zhou Z, Huang J, Chen M.

Sci Rep. 2015 Oct 21;5:15263. doi: 10.1038/srep15263.


The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming.

Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Skerl S, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YC, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng S, Rizk N, Wen YY, Lin X, Wang H, Wang H, Zhang A, Xia X, Wu Y, Habra M, Yang W, Pusztai L, Yeung SC, Lee MH.

Nat Commun. 2015 Jul 16;6:7530. doi: 10.1038/ncomms8530.


Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.

Xu L, Gao H, Huang J, Wang H, Zhou Z, Zhang Y, Li S, Chen M.

J Gastroenterol Hepatol. 2015 Jun;30(6):1032-9. doi: 10.1111/jgh.12910.


CSN6 drives carcinogenesis by positively regulating Myc stability.

Chen J, Shin JH, Zhao R, Phan L, Wang H, Xue Y, Post SM, Ho Choi H, Chen JS, Wang E, Zhou Z, Tseng C, Gully C, Velazquez-Torres G, Fuentes-Mattei E, Yeung G, Qiao Y, Chou PC, Su CH, Hsieh YC, Hsu SL, Ohshiro K, Shaikenov T, Wang H, Yeung SC, Lee MH.

Nat Commun. 2014 Nov 14;5:5384. doi: 10.1038/ncomms6384.


Clinicopathologic factors predicting outcomes in patients with gastrointestinal stromal tumors of the rectum and colon.

Zhou Z, Chen Z, Chen M, Wang R, Yin Y, Yao Y.

Tumour Biol. 2014 May;35(5):4357-62. doi: 10.1007/s13277-013-1572-7. Epub 2013 Dec 28.


Optimal use of adjuvant chemotherapy in stage II colorectal cancer.

Zhou Z, Wu X, Wang R, Li L, Lu Z, Chen G, Fang Y, Pan Z.

Int J Colorectal Dis. 2011 Jul;26(7):867-73. doi: 10.1007/s00384-011-1177-9. Epub 2011 Mar 24.


Supplemental Content

Loading ...
Support Center